CN Stock MarketDetailed Quotes

002644 Lanzhou Foci Pharmaceutical

Watchlist
  • 8.44
  • -0.26-2.99%
Trading Dec 13 13:31 CST
4.31BMarket Cap93.78P/E (TTM)

Lanzhou Foci Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-19.75%708.53M
-20.26%498.88M
-13.85%274.33M
11.58%1.16B
26.42%882.92M
35.49%625.66M
34.43%318.45M
27.49%1.04B
5.16%698.41M
19.38%461.79M
Operating revenue
-19.75%708.53M
-20.26%498.88M
-13.85%274.33M
11.58%1.16B
26.42%882.92M
35.49%625.66M
34.43%318.45M
27.49%1.04B
5.16%698.41M
19.38%461.79M
Other operating revenue
----
34.60%1.73M
----
244.39%5.45M
----
-12.14%1.29M
----
-80.83%1.58M
----
-73.75%1.47M
Total operating cost
-20.99%651.59M
-20.96%449.71M
-15.81%245.79M
13.57%1.08B
27.28%824.71M
39.11%568.96M
38.04%291.95M
26.21%950.2M
6.35%647.96M
15.25%409M
Operating cost
-22.45%481.63M
-21.47%334.87M
-17.83%189.02M
8.77%801.84M
24.56%621.04M
36.13%426.42M
37.93%230.04M
24.00%737.18M
6.80%498.61M
10.46%313.25M
Operating tax surcharges
5.65%10M
1.43%6.56M
29.16%3.57M
-8.24%13.36M
2.01%9.46M
-2.27%6.47M
-12.13%2.76M
-1.73%14.56M
-10.10%9.28M
-1.28%6.62M
Operating expense
-19.42%93.06M
-25.43%61.68M
-13.29%27.98M
33.79%153.73M
35.77%115.48M
53.24%82.71M
26.14%32.27M
41.39%114.9M
-9.65%85.06M
32.83%53.97M
Administration expense
-19.79%49.5M
-15.72%34.63M
-13.36%18.77M
24.64%84.29M
34.14%61.71M
36.08%41.09M
66.63%21.67M
30.60%67.63M
31.81%46M
31.41%30.19M
Financial expense
-2.58%-4.36M
-0.34%-2.65M
58.87%-446.91K
34.72%-4.97M
20.17%-4.25M
27.22%-2.64M
-5.22%-1.09M
13.62%-7.62M
28.95%-5.32M
33.89%-3.63M
-Interest expense (Financial expense)
-41.67%973.58K
-41.45%415.45K
----
-8.10%1.24M
--1.67M
-27.09%709.58K
----
42.79%1.35M
----
97.71%973.19K
-Interest Income (Financial expense)
-4.47%-5.45M
12.26%-3.1M
----
28.55%-5.37M
---5.21M
24.49%-3.54M
----
26.36%-7.51M
----
22.28%-4.68M
Research and development
2.36%21.77M
-1.93%14.62M
9.37%6.89M
31.29%30.93M
48.27%21.27M
73.54%14.91M
56.43%6.3M
21.69%23.56M
36.02%14.34M
32.71%8.59M
Credit Impairment Loss
-724.10%-21.14M
-497.19%-13.81M
-345.87%-8M
37.23%-14.64M
110.93%3.39M
271.99%3.48M
54.89%-1.79M
-110.31%-23.32M
856.25%1.61M
174.62%934.64K
Asset Impairment Loss
-108.02%-17.69K
-107.79%-17.69K
--0
-737.48%-1.06M
--220.64K
--227.14K
-409.83%-227.14K
57.76%-126.3K
----
----
Other net revenue
-156.61%-10.63M
-147.48%-6.92M
-251.82%-5.54M
-101.35%-689.03K
20.24%18.77M
67.17%14.57M
1,662.83%3.65M
7.01%50.95M
-44.96%15.61M
-59.74%8.71M
Invest income
-646.73%-6.52M
-333.26%-3.41M
-525.78%-2.61M
-246.29%-4.49M
134.85%1.19M
153.89%1.46M
--612.81K
-68.76%-1.3M
-372.24%-3.42M
-339.55%-2.71M
-Including: Investment income associates
-648.87%-6.56M
-338.27%-3.45M
-525.78%-2.61M
-14.14%-4.56M
--1.19M
--1.45M
--612.81K
-105.64%-4M
----
----
Asset deal income
--11.68K
--11.68K
--175.71
----
----
----
--0
-100.00%704.87
----
----
Other revenue
21.98%17.04M
9.71%10.31M
0.04%5.06M
-74.24%19.5M
-19.84%13.97M
-10.43%9.4M
23.12%5.06M
131.73%75.7M
-34.55%17.43M
-51.95%10.49M
Operating profit
-39.83%46.32M
-40.71%42.26M
-23.72%23M
-41.82%83.27M
16.52%76.98M
15.88%71.27M
17.84%30.15M
27.40%143.14M
-20.65%66.06M
14.80%61.5M
Add:Non operating Income
-49.05%32.96K
-92.48%4.38K
-89.68%4.22K
-36.83%116.42K
-76.42%64.69K
-71.93%58.23K
-26.17%40.92K
132.19%184.29K
-27.66%274.34K
-38.75%207.49K
Less:Non operating expense
-33.33%679.81K
-53.50%470.84K
595.80%400.83K
-86.13%1.75M
-80.05%1.02M
-65.88%1.01M
691.31%57.61K
675.14%12.61M
5,484.58%5.11M
1,753.72%2.97M
Total profit
-39.92%45.67M
-40.57%41.79M
-25.00%22.6M
-37.54%81.64M
24.17%76.02M
19.70%70.32M
17.55%30.14M
17.96%130.72M
-26.71%61.22M
9.28%58.74M
Less:Income tax cost
-66.03%5.22M
-61.51%4.73M
-36.43%3.96M
-36.73%13.52M
91.49%15.37M
67.36%12.28M
52.35%6.23M
23.54%21.37M
-36.88%8.03M
16.22%7.34M
Net profit
-33.30%40.45M
-36.13%37.06M
-22.01%18.64M
-37.70%68.12M
14.01%60.65M
12.90%58.03M
10.95%23.9M
16.93%109.35M
-24.88%53.19M
8.35%51.4M
Net profit from continuing operation
-33.30%40.45M
-36.13%37.06M
-22.01%18.64M
-37.70%68.12M
14.01%60.65M
12.90%58.03M
--23.9M
16.93%109.35M
-24.88%53.19M
8.35%51.4M
Less:Minority Profit
145.73%1.38M
264.38%968.58K
2,360.15%254.35K
34.40%932.29K
77.02%559.86K
60.71%265.82K
-123.04%-11.25K
168.11%693.66K
803.31%316.27K
214.68%165.4K
Net profit of parent company owners
-34.97%39.07M
-37.52%36.1M
-23.11%18.39M
-38.16%67.19M
13.63%60.09M
12.74%57.77M
11.25%23.92M
16.51%108.65M
-25.29%52.88M
7.68%51.24M
Earning per share
Basic earning per share
-35.00%0.0765
-37.49%0.0707
-23.08%0.036
-38.16%0.1316
13.72%0.1177
12.31%0.1131
11.16%0.0468
16.54%0.2128
-25.32%0.1035
8.40%0.1007
Diluted earning per share
-35.00%0.0765
-37.49%0.0707
-23.08%0.036
-38.16%0.1316
13.72%0.1177
12.31%0.1131
11.16%0.0468
16.54%0.2128
-25.32%0.1035
8.40%0.1007
Other composite income
1,166.78%487.79K
938.09%496.37K
-191.29%-241.98K
-20.04%38.51K
87.84%47.82K
3,125.98%265.07K
48.16K
25.46K
Other composite income of parent company owners
1,094.39%251.52K
878.77%255.94K
----
-191.29%-132.33K
-16.67%21.06K
87.84%26.15K
----
1,664.21%144.96K
--25.27K
--13.92K
Other composite income of minority owners
1,254.14%236.28K
1,009.68%240.43K
----
-191.29%-109.65K
-23.77%17.45K
87.84%21.67K
----
--120.11K
--22.89K
--11.53K
Total composite income
-32.54%40.94M
-35.33%37.56M
-22.01%18.64M
-38.07%67.88M
13.98%60.68M
12.94%58.08M
10.95%23.9M
17.20%109.61M
-24.81%53.24M
8.41%51.43M
Total composite income of parent company owners
-34.58%39.32M
-37.10%36.35M
-23.11%18.39M
-38.37%67.06M
13.62%60.11M
12.76%57.79M
11.25%23.92M
16.65%108.8M
-25.25%52.9M
7.71%51.25M
Total composite income of minority owners
179.23%1.61M
320.55%1.21M
2,360.15%254.35K
1.09%822.64K
70.21%577.31K
62.48%287.49K
-123.04%-11.25K
214.53%813.77K
868.68%339.16K
222.68%176.94K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lianda Certified Public Accountants (Special General Partnership)
--
--
--
Lianda Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -19.75%708.53M-20.26%498.88M-13.85%274.33M11.58%1.16B26.42%882.92M35.49%625.66M34.43%318.45M27.49%1.04B5.16%698.41M19.38%461.79M
Operating revenue -19.75%708.53M-20.26%498.88M-13.85%274.33M11.58%1.16B26.42%882.92M35.49%625.66M34.43%318.45M27.49%1.04B5.16%698.41M19.38%461.79M
Other operating revenue ----34.60%1.73M----244.39%5.45M-----12.14%1.29M-----80.83%1.58M-----73.75%1.47M
Total operating cost -20.99%651.59M-20.96%449.71M-15.81%245.79M13.57%1.08B27.28%824.71M39.11%568.96M38.04%291.95M26.21%950.2M6.35%647.96M15.25%409M
Operating cost -22.45%481.63M-21.47%334.87M-17.83%189.02M8.77%801.84M24.56%621.04M36.13%426.42M37.93%230.04M24.00%737.18M6.80%498.61M10.46%313.25M
Operating tax surcharges 5.65%10M1.43%6.56M29.16%3.57M-8.24%13.36M2.01%9.46M-2.27%6.47M-12.13%2.76M-1.73%14.56M-10.10%9.28M-1.28%6.62M
Operating expense -19.42%93.06M-25.43%61.68M-13.29%27.98M33.79%153.73M35.77%115.48M53.24%82.71M26.14%32.27M41.39%114.9M-9.65%85.06M32.83%53.97M
Administration expense -19.79%49.5M-15.72%34.63M-13.36%18.77M24.64%84.29M34.14%61.71M36.08%41.09M66.63%21.67M30.60%67.63M31.81%46M31.41%30.19M
Financial expense -2.58%-4.36M-0.34%-2.65M58.87%-446.91K34.72%-4.97M20.17%-4.25M27.22%-2.64M-5.22%-1.09M13.62%-7.62M28.95%-5.32M33.89%-3.63M
-Interest expense (Financial expense) -41.67%973.58K-41.45%415.45K-----8.10%1.24M--1.67M-27.09%709.58K----42.79%1.35M----97.71%973.19K
-Interest Income (Financial expense) -4.47%-5.45M12.26%-3.1M----28.55%-5.37M---5.21M24.49%-3.54M----26.36%-7.51M----22.28%-4.68M
Research and development 2.36%21.77M-1.93%14.62M9.37%6.89M31.29%30.93M48.27%21.27M73.54%14.91M56.43%6.3M21.69%23.56M36.02%14.34M32.71%8.59M
Credit Impairment Loss -724.10%-21.14M-497.19%-13.81M-345.87%-8M37.23%-14.64M110.93%3.39M271.99%3.48M54.89%-1.79M-110.31%-23.32M856.25%1.61M174.62%934.64K
Asset Impairment Loss -108.02%-17.69K-107.79%-17.69K--0-737.48%-1.06M--220.64K--227.14K-409.83%-227.14K57.76%-126.3K--------
Other net revenue -156.61%-10.63M-147.48%-6.92M-251.82%-5.54M-101.35%-689.03K20.24%18.77M67.17%14.57M1,662.83%3.65M7.01%50.95M-44.96%15.61M-59.74%8.71M
Invest income -646.73%-6.52M-333.26%-3.41M-525.78%-2.61M-246.29%-4.49M134.85%1.19M153.89%1.46M--612.81K-68.76%-1.3M-372.24%-3.42M-339.55%-2.71M
-Including: Investment income associates -648.87%-6.56M-338.27%-3.45M-525.78%-2.61M-14.14%-4.56M--1.19M--1.45M--612.81K-105.64%-4M--------
Asset deal income --11.68K--11.68K--175.71--------------0-100.00%704.87--------
Other revenue 21.98%17.04M9.71%10.31M0.04%5.06M-74.24%19.5M-19.84%13.97M-10.43%9.4M23.12%5.06M131.73%75.7M-34.55%17.43M-51.95%10.49M
Operating profit -39.83%46.32M-40.71%42.26M-23.72%23M-41.82%83.27M16.52%76.98M15.88%71.27M17.84%30.15M27.40%143.14M-20.65%66.06M14.80%61.5M
Add:Non operating Income -49.05%32.96K-92.48%4.38K-89.68%4.22K-36.83%116.42K-76.42%64.69K-71.93%58.23K-26.17%40.92K132.19%184.29K-27.66%274.34K-38.75%207.49K
Less:Non operating expense -33.33%679.81K-53.50%470.84K595.80%400.83K-86.13%1.75M-80.05%1.02M-65.88%1.01M691.31%57.61K675.14%12.61M5,484.58%5.11M1,753.72%2.97M
Total profit -39.92%45.67M-40.57%41.79M-25.00%22.6M-37.54%81.64M24.17%76.02M19.70%70.32M17.55%30.14M17.96%130.72M-26.71%61.22M9.28%58.74M
Less:Income tax cost -66.03%5.22M-61.51%4.73M-36.43%3.96M-36.73%13.52M91.49%15.37M67.36%12.28M52.35%6.23M23.54%21.37M-36.88%8.03M16.22%7.34M
Net profit -33.30%40.45M-36.13%37.06M-22.01%18.64M-37.70%68.12M14.01%60.65M12.90%58.03M10.95%23.9M16.93%109.35M-24.88%53.19M8.35%51.4M
Net profit from continuing operation -33.30%40.45M-36.13%37.06M-22.01%18.64M-37.70%68.12M14.01%60.65M12.90%58.03M--23.9M16.93%109.35M-24.88%53.19M8.35%51.4M
Less:Minority Profit 145.73%1.38M264.38%968.58K2,360.15%254.35K34.40%932.29K77.02%559.86K60.71%265.82K-123.04%-11.25K168.11%693.66K803.31%316.27K214.68%165.4K
Net profit of parent company owners -34.97%39.07M-37.52%36.1M-23.11%18.39M-38.16%67.19M13.63%60.09M12.74%57.77M11.25%23.92M16.51%108.65M-25.29%52.88M7.68%51.24M
Earning per share
Basic earning per share -35.00%0.0765-37.49%0.0707-23.08%0.036-38.16%0.131613.72%0.117712.31%0.113111.16%0.046816.54%0.2128-25.32%0.10358.40%0.1007
Diluted earning per share -35.00%0.0765-37.49%0.0707-23.08%0.036-38.16%0.131613.72%0.117712.31%0.113111.16%0.046816.54%0.2128-25.32%0.10358.40%0.1007
Other composite income 1,166.78%487.79K938.09%496.37K-191.29%-241.98K-20.04%38.51K87.84%47.82K3,125.98%265.07K48.16K25.46K
Other composite income of parent company owners 1,094.39%251.52K878.77%255.94K-----191.29%-132.33K-16.67%21.06K87.84%26.15K----1,664.21%144.96K--25.27K--13.92K
Other composite income of minority owners 1,254.14%236.28K1,009.68%240.43K-----191.29%-109.65K-23.77%17.45K87.84%21.67K------120.11K--22.89K--11.53K
Total composite income -32.54%40.94M-35.33%37.56M-22.01%18.64M-38.07%67.88M13.98%60.68M12.94%58.08M10.95%23.9M17.20%109.61M-24.81%53.24M8.41%51.43M
Total composite income of parent company owners -34.58%39.32M-37.10%36.35M-23.11%18.39M-38.37%67.06M13.62%60.11M12.76%57.79M11.25%23.92M16.65%108.8M-25.25%52.9M7.71%51.25M
Total composite income of minority owners 179.23%1.61M320.55%1.21M2,360.15%254.35K1.09%822.64K70.21%577.31K62.48%287.49K-123.04%-11.25K214.53%813.77K868.68%339.16K222.68%176.94K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lianda Certified Public Accountants (Special General Partnership)------Lianda Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.